Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Friday, July 4, 2025 in observance of the Fourth of July holiday.  Have a healthy, happy holiday.

Hide
Quest Diagnostics

High Levels of Myeloperoxidase are Similar Across ASCVD Risk Groups and are Associated with Markers of Liver Fibrosis and Kidney Function in a Workforce Population

AHA 2021: Scientific Sessions if the American Heart Association
Nashville, TN, November 13-15, 2021

High Levels of Myeloperoxidase are Similar Across ASCVD Risk Groups and are Associated with Markers of Liver Fibrosis and Kidney Function in a Workforce Population

Authors: Iakoubova OA, Judy Louie, Shiffman D, McPhaul MJ, Penn MS,

Specialties: Endocrinology, Cardiovascular disease

Download key summary

Related content

Publication
Association between liver and chronic kidney disease on hemoglobin A1c concentrations
On-Demand Webinar
The Continuum of Kidney Disease Care: From Identification to referral
Test FAQ
Kidney Profile
Publication
Differences in HDL-Bound Apolipoproteins in Patients with Advanced Liver Fibrosis due to Nonalcoholic Fatty Liver Disease

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.